Jun 10, 2025
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
May 28, 2025
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
May 14, 2025
Illumina To Webcast Upcoming Investor Conference
May 13, 2025
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
May 01, 2025
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
Mar 19, 2025
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery
Mar 10, 2025
Illumina addresses recent developments in China
Feb 24, 2025
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology
Feb 19, 2025
Illumina unveils first-of-its-kind spatial transcriptomics technology
Jan 13, 2025
Illumina and NVIDIA collaborate to decode biology and propel precision health
Jan 13, 2025
Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples
Jan 07, 2025
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
Dec 04, 2024
Illumina To Webcast Upcoming Investor Conference
Nov 04, 2024
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024
Oct 31, 2024
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting
Sep 03, 2024
European Court of Justice rules in favor of Illumina in jurisdictional appeal
Aug 27, 2024
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
Aug 13, 2024
Illumina announces strategy to accelerate value creation
Aug 06, 2024
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024
Aug 05, 2024
Illumina launches new oncology menu for NovaSeq X Series customers